Zobrazeno 1 - 10
of 23 121
pro vyhledávání: '"Hamilton, SR"'
Autor:
Gettinger SN; Yale University, New Haven, CT., Song Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Reckamp KL; Cedars Sinai Medical Center, Los Angeles, CA., Moscow JA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Hamilton SR; City of Hope National Medical Center, Duarte, CA., Kong XT; UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, CA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2300725.
Publikováno v:
In Blood 16 June 2011 117(24):6739-6739
Autor:
Connolly RM; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.; Cancer Research @UCC, College of Medicine and Health, University College Cork, Ireland., Wang V; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Hyman DM; Memorial Sloan Kettering Cancer Center, New York, New York., Grivas P; University of Washington, Fred Hutchinson Cancer Center, Seattle, Washington., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Wright JJ; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Sharon E; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Gray RJ; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland., Hamilton SR; City of Hope National Medical Center, Duarte, California., Wang J; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, Texas., Wisinski KB; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, Texas., O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 01; Vol. 30 (7), pp. 1273-1280.
Autor:
Gong J; Cedars-Sinai Medical Center, Los Angeles, CA., Mita AC; Cedars-Sinai Medical Center, Los Angeles, CA., Wei Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Cheng HH; University of Washington, Seattle, WA., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA., Wright JJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Gray RC; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Bethesda, MD., Hamilton SR; City of Hope Comprehensive Cancer Center, Duarte, CA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300407.
Autor:
Chen MF; Memorial Sloan Kettering Cancer Center, New York, NY., Song Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Yu HA; Memorial Sloan Kettering Cancer Center, New York, NY., Sequist LV; Massachusetts General Hospital Cancer Center, Boston, MA., Lovly CM; Vanderbilt-Ingram Cancer Center, Nashville, TN., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA., Moscow JA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Hamilton SR; City of Hope National Medical Center, Duarte, CA., Umemura Y; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300454.
Autor:
Gong J; Cedars-Sinai Medical Center, Los Angeles, CA., Mita AC; Cedars-Sinai Medical Center, Los Angeles, CA., Wei Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Cheng HH; University of Washington, Seattle, WA., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA., Wright JJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Gray RC; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Bethesda, MD., Hamilton SR; City of Hope Comprehensive Cancer Center, Duarte, CA., Alva AS; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300406.
Autor:
Young, Beth
Publikováno v:
Illinois Heritage; Jul/Aug2020, Vol. 23 Issue 4, p30-31, 2p
Autor:
O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA. peter.odwyer@pennmedicine.upenn.edu., Gray RJ; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Li S; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Wang V; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Iafrate AJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sklar J; Yale University, New Haven, CT, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Coffey B; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA., Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, USA., Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA., Hamilton SR; City of Hope National Medical Center, Duarte, CA, USA., Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1349-1357. Date of Electronic Publication: 2023 Jun 15.
Autor:
Clark AS; University of Pennsylvania, Philadelphia, Pennsylvania., Hong F; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Finn RS; University of California, Los Angeles, Los Angeles, California., DeMichele AM; University of Pennsylvania, Philadelphia, Pennsylvania., Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Zwiebel J; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Arnaldez FI; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Gray RJ; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Wang V; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Patton D; Center for Biomedical Informatics and Information Technology, NCI, Bethesda, Maryland., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland., Hamilton SR; City of Hope National Medical Center, Duarte, California., Copur MS; Catholic Health Initiatives NCORP, Grand Island, Nebraska., Kasbari SS; Southeast COR NCORP, Goldsboro, North Carolina., Thind R; University of Kentucky, Lexington, Kentucky., Conley BA; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, Texas., O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania., Harris LN; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Chen AP; Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 14; Vol. 29 (8), pp. 1477-1483.